» Articles » PMID: 30121818

Potential Anticoagulant Activity of Trypsin Inhibitor Purified from an Isolated Marine Bacterium Oceanimonas Sp. BPMS22 and Its Kinetics

Overview
Specialties Biology
Biotechnology
Date 2018 Aug 20
PMID 30121818
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Protease inhibitors control major biological protease activities to maintain physiological homeostasis. Marine bacteria isolated from oligotrophic conditions could be taxonomically distinct, metabolically unique, and offers a wide variety of biochemicals. In the present investigation, marine sediments were screened for the potential bacteria that can produce trypsin inhibitors. A moderate halotolerant novel marine bacterial strain of Oceanimonas sp. BPMS22 was isolated, identified, and characterized. The effect of various process parameters like salt concentration, temperature, and pH was studied on the growth of the bacteria and production of trypsin inhibitor. Further, the trypsin inhibitor was purified to near homogeneity using anion exchange, size exclusion, and affinity chromatography. The purified trypsin inhibitor was found to competitively inhibit trypsin activity with an inhibition coefficient, K, of 3.44 ± 0.13 μM and second-order association rate constant, k, of 1.08 × 10 M S. The proteinaceous trypsin inhibitor had a molecular weight of approximately 30 kDa. The purified trypsin inhibitor showed anticoagulant activity on the human blood samples.

Citing Articles

Association Mechanism and Conformational Changes in Trypsin on Its Interaction with Atrazine: A Multi- Spectroscopic and Biochemical Study with Computational Approach.

A Khayyat A, Zargar S, Wani T, Rehman M, Khan A Int J Mol Sci. 2022; 23(10).

PMID: 35628445 PMC: 9146720. DOI: 10.3390/ijms23105636.


Marine Antithrombotics.

Dwivedi R, Pomin V Mar Drugs. 2020; 18(10).

PMID: 33066214 PMC: 7602030. DOI: 10.3390/md18100514.

References
1.
Celhar T, Batista Napotnik T, Obreza A, Zega A, Anderluh P, Kikelj D . Azaphenylalanine-based serine protease inhibitors induce caspase-mediated apoptosis. Eur J Pharmacol. 2008; 602(1):15-22. DOI: 10.1016/j.ejphar.2008.11.008. View

2.
Prezelj A, Anderluh P, Peternel L, Urleb U . Recent advances in serine protease inhibitors as anticoagulant agents. Curr Pharm Des. 2007; 13(3):287-312. DOI: 10.2174/138161207779313605. View

3.
Lawandi J, Gerber-Lemaire S, Juillerat-Jeanneret L, Moitessier N . Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors. J Med Chem. 2010; 53(9):3423-38. DOI: 10.1021/jm901104g. View

4.
Zhang H, Fei R, Xue B, Yu S, Zhang Z, Zhong S . Pnserpin: A Novel Serine Protease Inhibitor from Extremophile Pyrobaculum neutrophilum. Int J Mol Sci. 2017; 18(1). PMC: 5297747. DOI: 10.3390/ijms18010113. View

5.
Margesin R, Schinner F . Potential of halotolerant and halophilic microorganisms for biotechnology. Extremophiles. 2001; 5(2):73-83. DOI: 10.1007/s007920100184. View